Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

02/08/2024 06:00

Aug 2 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             25.41               24.75           106.00    
                 (+2.7 pct)          (-10.6 pct)      (+3.0 pct)  
  Operating          2.19                2.52             7.50    
                 (-13.0 pct)         (-41.0 pct)      (+29.3 pct) 
  Recurring          2.37                2.59             7.70    
                 (-8.7 pct)          (-41.3 pct)      (+27.5 pct) 
  Net                1.55                1.69             5.60    
                 (-7.9 pct)          (-46.5 pct)      (+23.1 pct) 
  EPS             43.85 yen           46.24 yen       157.96 yen  
  Ann Div                             80.00 yen        80.00 yen  
  -Q2 div                             40.00 yen        40.00 yen  
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T